Evidence map›Paper›PMID 40181341›Full record

ArticleBMC public health2025

Global lung cancer burden attributable to air fine particulate matter and tobacco smoke exposure: spatiotemporal patterns, sociodemographic characteristics, and transnational inequalities from 1990 to 2021.

Yudong Zhang, Wenxi Wang, Keyao Dai, Ying Huang, Runchen Wang, Danjie He, Jianxing He, Hengrui Liang

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yudong Zhang *Department of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Wenxi Wang *Executive Office, National Center for Respiratory Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Keyao DaiDepartment of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Ying HuangDepartment of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Runchen WangDepartment of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Danjie HeDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Jianxing HeDepartment of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. hejx@vip.163.com.
Hengrui LiangDepartment of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. liang_hengrui@163.com.

Funding

Guangzhou National Laboratory SRPG22-017
6 · The paper itself

Abstract

backgroundAir fine particulate matter and tobacco smoke exposure are primary risk factors for lung cancer. However, their recent global exposure levels, attributable burden, and patterns of inequalities remain insufficiently quantified.

methodsUtilizing the Global Burden of Disease 2021 study, we analyzed exposure levels of air fine particulate matter (ambient and household) and tobacco smoke (active and secondhand) by age-standardized summary exposure value (ASEV). Age-standardized mortality rate (ASMR) and age-standardized disability-adjusted life years rate (ASDR) were used to assess their attributable lung cancer burden globally. Temporal patterns were examined using weighted average annual percentage change (WAPC). Cross-national health inequalities were evaluated with the concentration index (CI) for ASMR and slope index of inequality (SII) for ASDR.

resultsIn 2021, air fine particulate (PM2.5) exposure peaked in low socio-demographic index (SDI) countries, while tobacco exposure was highest in high-middle SDI regions. Globally, air PM2.5 contributed to 374.21 thousand (95% uncertainty interval [UI]: 236.36, 520.26) lung cancer deaths [ambient: 297.60 thousand (95% UI: 183.71, 414.74); household: 76.48 thousand (95% UI: 28.6, 187.34)], whereas tobacco exposure caused 1,238.65 thousand (95% UI: 1,075.69, 1,423.12) deaths [active smoking: 1,195.80 thousand (95% UI: 1,054.67, 1,359.22); secondhand smoke: 97.91 thousand (95% UI: 11.96, 184.91)]. High-middle SDI countries and the Southeast Asia, East Asia, and Oceania regions bore the greatest burden. The attributable burden for males exceeded that for females by approximately twofold for air PM2.5 and fivefold for tobacco exposure. The 55 + age group showed disproportionately high impacts despite lower exposure. From 1990 to 2021, the ASMR attributable to air PM2.5 and tobacco exposure changed annually by -1.32% (95% confidence interval [CI]: -1.48, -1.16) and - 0.95% (95% CI: -1.03, -0.88), respectively. The attributable ASDR also showed declining trends. Regarding translational health inequality, the air PM2.5 attributable lung cancer burden shifted from high to low SDI countries (CI: 0.05 to -0.10, SII: 31.00 to -35.50), while the tobacco-attributable burden persisted in higher SDI countries, albeit with diminishing inequalities (CI: 0.34 to 0.25, SII: 572.20 to 304.60).

conclusionsThis up-to-date study provides a comprehensive perspective on air fine particulate matter and tobacco smoke exposure's impact on lung cancer burden, highlighting its widespread nature, substantial impact, unequal distribution, and preventability. The findings call for targeted interventions and global cooperation across socioeconomic levels to reduce the overall lung cancer burden in the post-pandemic era.

Indexed as

Environmental ExposureGlobal HealthHealth Status DisparitiesLung NeoplasmsParticulate MatterTobacco Smoke PollutionAdultAgedDisability-Adjusted Life YearsFemaleGlobal Burden of DiseaseHumansMaleMiddle AgedRisk FactorsSociodemographic FactorsParticulate MatterTobacco Smoke PollutionGlobal burden of diseaseHealth inequalitiesLung cancerParticulate matterTobacco use

Identifiers

PMID40181341
PMCPMC11969995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.